Literature DB >> 12813121

Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond.

Martin B Keller1.   

Abstract

During the past decade, evidence from research on mood disorders has demonstrated that remission is the optimal outcome of treatment. However, there continues to be considerable variability in the specific characteristics that are accepted as indicators of remission. Increasing knowledge of mood disorders and their underlying mechanisms may allow for the development of a new diagnostic and assessment system that no longer is based solely on symptoms and other descriptive phenomena. Continued advances in neuroscience may allow for more knowledge of the underlying neurobiological status and more accurate assessments of the underlying disease state and response to treatment, thus enabling physicians to use treatments that will most effectively bring patients back to euthymia and a truly disease-free healthy state. Until then, remission should continue to be based on the descriptive and experiential phenomena of symptoms and psychosocial functioning.

Entities:  

Mesh:

Year:  2003        PMID: 12813121     DOI: 10.1001/jama.289.23.3152

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  100 in total

1.  Depression: We've Come a Long Way!

Authors:  Larry Culpepper
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-08

2.  Pilot study of treatment for major depression among women prisoners with substance use disorder.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Psychiatr Res       Date:  2012-06-12       Impact factor: 4.791

3.  A Review of Brain Stimulation Treatments for Late-Life Depression.

Authors:  Daniel M Blumberger; Jonathan H Hsu; Zafiris J Daskalakis
Journal:  Curr Treat Options Psychiatry       Date:  2015-09-28

4.  Initial rate of improvement in relation to remission of major depressive disorder in primary care.

Authors:  Anton C Vergouwen; Huibert Burger; Frank Koerselman; Theo J Verheij
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

5.  Four maternal characteristics determine the 12-month course of chronic severe postpartum depressive symptoms.

Authors:  Sheehan D Fisher; Dorothy K Sit; Amy Yang; Jody D Ciolino; Jackie K Gollan; Katherine L Wisner
Journal:  Depress Anxiety       Date:  2019-01-15       Impact factor: 6.505

6.  A shared effect of paroxetine treatment on gray matter volume in depressive patients with and without childhood maltreatment: A voxel-based morphometry study.

Authors:  Xiao-Wen Lu; Hua Guo; Jing-Rong Sun; Qiang-Li Dong; Fu-Tao Zhao; Xu-Hong Liao; Li Zhang; Yan Zhang; Wei-Hui Li; Ze-Xuan Li; Tie-Bang Liu; Yong He; Ming-Rui Xia; Ling-Jiang Li
Journal:  CNS Neurosci Ther       Date:  2018-09-12       Impact factor: 5.243

Review 7.  Evidence for the management of adolescent depression.

Authors:  R Eric Lewandowski; Mary C Acri; Kimberly E Hoagwood; Mark Olfson; Greg Clarke; William Gardner; Sarah Hudson Scholle; Sepheen Byron; Kelly Kelleher; Harold A Pincus; Samantha Frank; Sarah M Horwitz
Journal:  Pediatrics       Date:  2013-09-16       Impact factor: 7.124

Review 8.  Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.

Authors:  Hans-Jürgen Möller; Heinz Grunze; Karl Broich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-04       Impact factor: 5.270

9.  Effects of Restricted Time in Bed on Antidepressant Treatment Response: A Randomized Controlled Trial.

Authors:  J Todd Arnedt; Leslie M Swanson; Richard R Dopp; Holli S Bertram; Ann J Mooney; Edward D Huntley; Robert F Hoffmann; Roseanne Armitage
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

10.  Improvement in functional outcomes with adjunctive aripiprazole versus placebo in major depressive disorder: a pooled post hoc analysis of 3 short-term studies.

Authors:  Tanya J Fabian; Zachary J Cain; Diane Ammerman; James M Eudicone; Yan Tang; Linda M Rollin; Robert A Forbes; Robert M Berman; Ross A Baker
Journal:  Prim Care Companion CNS Disord       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.